Author Guidelines
1. SUBMISSION
Thank you for your interest in Alimentary Pharmacology & Therapeutics. Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium, in which case, such should be clearly stated.
Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/APT
The submission system will prompt you to use an ORCID iD (a unique author identifier) to help distinguish your work from that of other researchers. Click here to find out more.
Click here for more details on how to use ScholarOne.
For help with submissions, please contact: dorisedwards.apt@gmail.com
We look forward to your submission.
Data Protection and Privacy
By submitting a manuscript to, or reviewing for, this publication, your name, email address, institutional affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
2. AIMS AND SCOPE
Alimentary Pharmacology & Therapeutics (AP&T) is an international journal of gastroenterology and hepatology. The journal accepts original papers and systematic reviews concerned with clinical gastroenterology and hepatology. AP&T is particularly interested in therapies and diagnostics, including all aspects of translation from bench to bedside: identification of novel therapeutic targets, epidemiology, clinical trials, drug safety and meta-analyses. Descriptions of adverse effects (but not case reports) and pharmacoepidemiological and toxicological aspects will also be considered. AP&T only publishes studies performed in human subjects.
Preprint Policy
Alimentary Pharmacology & Therapeutics will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Alimentary Pharmacology & Therapeutics publishes a number of different article types including:
• Original Articles
AP&T does not have an exact word count for any article, as all articles vary, but the introduction, methods, results, discussion and references should be approximately 12-20 pages of double-spaced A4 (with approximately 300 words per page – font size 12). Please insert the total word count (excluding summary) on the front page of your submitted article.
AP&T will consider all figures, tables and references which are relevant to the submitted manuscript but additional relevant text, tables, figures and references can also be submitted as Supporting Information – i.e. if the article is accepted for publication, you cite the Supporting Information within the text of the main article, and this can be viewed via a separate link at the end of the article.
• Systematic Reviews
A systematic review is a review of published literature addressing a specific research question. It should include an exhaustive search of the literature to date. The search strategy used should be reported within the paper. The authors should define eligibility criteria for included studies a priori, and describe these. There should be evidence of independent judging of study eligibility, performed by at least two authors, with the degree of agreement between authors described. Data extraction from individual studies should also be performed in duplicate, and there should be evidence that any differences in data extraction were discussed between authors, and resolved.
The reporting of systematic reviews should adhere to the PRISMA statement – (for further information please see section below under ETHICS). Further guidance is also available from the Cochrane organisation’s “Reviewer’s Handbook”.
• Reviews
A review article should still report the search strategy for the selection of relevant literature, but the approach may be less rigorous than described above, and the article might also reflect the personal experience and opinions of the Authors.
• Consensus Guidelines
Consensus Guidelines will be considered providing that they tackle an area of clinical importance, have authorship that represents a national, or preferably international grouping, and that uses a systematic approach to achieve consensus eg Delphi. The article should otherwise follow the guidelines for a Review Article, including a structured summary which should include the key recommendations.
• Systematic Reviews with Meta-analyses
A meta-analysis is a statistical approach to combining data from individual studies identified in a systematic review that address a single research question. Although it is perfectly acceptable to perform a systematic review without a meta-analysis, a meta-analysis cannot be conducted without first performing a systematic review of the published literature.
Again, the reporting of meta-analyses should adhere to the PRISMA statement (for further information please see section below under ETHICS). Further guidance is also available from the Cochrane organisation’s “Reviewer’s Handbook”.
• Randomised Clinical Trials
Please note: All randomised clinical trials must be registered with a clinical trials registry, or a statement provided in the paper to explain the omission.
‘Clinical trial' defined as 'any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes'), please provide details of the registry and the registration number in the Methods section of your paper, close to your statement about Ethical issues, plus quoting the registration number at the end of the final line of the Conclusions in your Summary. Clinical trial reports should include the power of the study design and any deviations from the proposed protocol should be reported within the Methods section of the paper.
• Letters to the Editor and Invited Editorials
Letters to the Editor and Invited Editorials are restricted to the discussion of papers already published in the journal (preferably within the last 18 – 24 months), WITH A MAXIMUM OF 500 WORDS, ONE TABLE OR FIGURE AND UP TO 10 REFERENCES.
• SuperFast papers
We offer a separate fast appraisal and publication service for manuscripts. A submission fee of US$1,500 (plus VAT in the UK), guarantees full peer review within 6 working days, but it does not guarantee acceptance. Once a manuscript is accepted in its final form, it will be published as an EarlyView paper (edited, typeset and as corrected final proofs) within 20 to 28 days, and in a full issue of the journal about one month later; full details below. This service will not slow the standard prompt service provided by the journal.
Authors planning to submit a SuperFast paper are encouraged to contact the Editorial Office in advance of submission, so that peer-review can be planned in advance. An invoice will be issued by Wiley for the submission fee on submission of the manuscript via our “Superfast” process – please provide full details to whom this invoice should be sent (including an email address and/or fax number).
4. PREPARING YOUR SUBMISSION
Parts of the Manuscript
The manuscript should be submitted in separate files: main text file; figures.
Main Text File
The text file should be presented in the following order:
i. A short informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
ii. A short running title of less than 40 characters;
iii. The full names of the authors (maximum 25);
iv. The authors' institutional affiliations where the work was conducted (maximum of two affiliations per author), with a footnote for any author’s present address if different from where the work was conducted;
v. Acknowledgments;
vi. Structured summary (not exceeding 250 words) and keywords;
vii. Main text - Introduction, Materials and Methods, Results, and Discussion;
viii. References;
ix. Tables (each table complete with title and footnotes);
x. Figure legends;
xi. Appendices (if relevant).
Figures and supporting information should be supplied as separate files.
Title
The title should be a short, informative and containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips).
Please note: it is the journal style for AP&T to include a prefix in the title for some article types: 'Review article: ...', 'Systematic review: ...', 'Systematic Review with Meta-analysis: ...', 'Randomised clinical trial: ...'.
Authorship
Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.
Acknowledgments
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Summary
For all papers other than editorials or letters, ie including Review articles, please provide a structured summary of up to 250 words containing the major keywords summarizing the article. This should be a concise summary of the whole paper, not just the conclusions, and it must be understandable without reference to the rest of the paper. It should include the headings: Background/Aims/Methods/Results/Conclusions. It should contain no citation to any other published work. Abbreviations and acronyms should be avoided in the Summary.
Keywords
Please provide 3-7 keywords.
Main Text
• The journal uses British spelling.
• AP&T does not have a strict total word count for articles (except for Letters and Editorials).
References
All references should be numbered consecutively in order of appearance. In text citations should cite references in consecutive order using Arabic superscript numerals.
For more information about this reference style, please see the AMA Manual of Style.
Reference examples follow:
Journal article
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/13652036/homepage/forauthors.html
